163 related articles for article (PubMed ID: 28068907)
1. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
Bieh KL; Weigel R; Smith H
BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
[TBL] [Abstract][Full Text] [Related]
2. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
McNally TW; de Wildt G; Meza G; Wiskin CMD
BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
[TBL] [Abstract][Full Text] [Related]
3. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
[TBL] [Abstract][Full Text] [Related]
4. Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.
Lajore BA; Aweke YH; Ayanto SY; Ayele M
BMC Health Serv Res; 2024 Apr; 24(1):542. PubMed ID: 38678263
[TBL] [Abstract][Full Text] [Related]
5. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
[TBL] [Abstract][Full Text] [Related]
6. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients' experiences in the era of rapid molecular diagnostic tests.
Naidoo P; van Niekerk M; du Toit E; Beyers N; Leon N
BMC Health Serv Res; 2015 Oct; 15():488. PubMed ID: 26511931
[TBL] [Abstract][Full Text] [Related]
7. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
[TBL] [Abstract][Full Text] [Related]
8. Ease and equity of access to free DR-TB services in Nigeria- a qualitative analysis of policies, structures and processes.
Oga-Omenka C; Bada F; Agbaje A; Dakum P; Menzies D; Zarowsky C
Int J Equity Health; 2020 Dec; 19(1):221. PubMed ID: 33302956
[TBL] [Abstract][Full Text] [Related]
9. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
[TBL] [Abstract][Full Text] [Related]
10. Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
Mpagama SG; Ezekiel MJ; Mbelele PM; Chongolo AM; Kibiki GS; de Guex KP; Heysell SK
BMC Public Health; 2020 Nov; 20(1):1667. PubMed ID: 33160327
[TBL] [Abstract][Full Text] [Related]
11. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective.
Morris MD; Quezada L; Bhat P; Moser K; Smith J; Perez H; Laniado-Laborin R; Estrada-Guzman J; Rodwell TC
Int J Tuberc Lung Dis; 2013 Jul; 17(7):954-60. PubMed ID: 23743315
[TBL] [Abstract][Full Text] [Related]
12. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
[TBL] [Abstract][Full Text] [Related]
13. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan.
Horter S; Stringer B; Gray N; Parpieva N; Safaev K; Tigay Z; Singh J; Achar J
BMC Infect Dis; 2020 Sep; 20(1):675. PubMed ID: 32938422
[TBL] [Abstract][Full Text] [Related]
14. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
[TBL] [Abstract][Full Text] [Related]
15. Support and unmet needs of patients undergoing multidrug-resistant tuberculosis (MDR-TB) treatment in southern Nigeria.
Oshi D; Chukwu J; Nwafor C; Chukwu NE; Meka AO; Anyim M; Ukwaja KN; Alobu I; Ekeke N; Oshi SN
Int J Health Plann Manage; 2020 Jul; 35(4):832-842. PubMed ID: 31849112
[TBL] [Abstract][Full Text] [Related]
16. Development of a Patient-Centred, Psychosocial Support Intervention for Multi-Drug-Resistant Tuberculosis (MDR-TB) Care in Nepal.
Khanal S; Elsey H; King R; Baral SC; Bhatta BR; Newell JN
PLoS One; 2017; 12(1):e0167559. PubMed ID: 28099475
[TBL] [Abstract][Full Text] [Related]
17. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
Horter S; Achar J; Gray N; Parpieva N; Tigay Z; Singh J; Stringer B
PLoS One; 2020; 15(11):e0242359. PubMed ID: 33237960
[TBL] [Abstract][Full Text] [Related]
18. Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.
Engel N; Ochodo EA; Karanja PW; Schmidt BM; Janssen R; Steingart KR; Oliver S
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD014877. PubMed ID: 35470432
[TBL] [Abstract][Full Text] [Related]
19. "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
Loveday M; Hlangu S; Furin J
PLoS One; 2020; 15(12):e0242604. PubMed ID: 33347448
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
